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Abstract
Chromosome 22q11.2 microdeletion syndrome is due to microdeletion of 22q11.2 region of
chromosome 22. It is a common microdeletion syndrome however mosaic cases are very rare and
reported only few previous occasions. In this report we describe two unrelated male children with
clinical features consistent with 22q11.2 microdeletion syndrome characterized by cardiac defect,
facial dysmorphism and developmental deficiency. One of the cases also had trigonocephaly.
Interphase & metaphase FISH with 22q11.2 probe demonstrated mosaicism for hemizygous
deletion of 22q11.2 region. Mosaicism is also observed in buccal cells as well as urine cells. Parents
were without any deletion. These two cases represent rare cases of mosaic 22q11.2 microdeletion
syndrome.
Background
The 22q11.2 microdeletion syndrome is the most com-
mon microdeletion syndrome with an estimated inci-
dence of one in 4000 births [1]. It has a wide phenotypic
spectrum. Almost all cases result from a common deletion
of chromosome 22q11.2 locus. Diagnosis of this micro-
deletion syndrome is based on prometaphase banding
cytogenetics [2], fluorescent in situ hybridization (FISH)
[3], array comparative genomic hybridization (aCGH)
[4], quantitative fluorescent polymerase chain reaction
(QFPCR) [5] with polymorphic micro satellite marker and
multiplex ligation dependent probe amplification
(MLPA) [6]. Interphase FISH is the prime method for
diagnosis of mosaicism. Interphase FISH, being the only
way to analyze large number of cells individually &
quickly, has the ability to diagnose mosaicism including
low level very easily and reliably. Diagnosis of 22q11.2
microdeletion mosaicism through FISH on amniocytes &
cord blood cells [7], on peripheral blood lymphocytes
[8,9] and on cardiac tissue [9] have been reported. In this
report we describe two male children with clinical features
of 22q11.2 microdeletion syndrome and FISH analysis
showed mosaicism for a deletion in the critical region
(22q11.2) in peripheral blood nucleated cells (both met-
aphase & interphase cells). Furthermore, one of the chil-
dren had trigonocephaly (premature closure of metopic
suture) in addition to features of 22q11.2 microdeletion
syndrome despite low level of deleted cells. Trigonoceph-
aly was reported only once in the literature [10]. We here
report two rare cases of mosaic 22q11.2 microdeletion
syndrome.
Case report
Case 1
A two years and ten months male child was referred from
Fateyabad, Haryana, India to our hospital for cardiac mal-
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formation (tetralogy of Fallot) and facial dysmorphism.
Pediatric geneticist referred the child to us to evaluate for
22q11.2 microdeletion syndrome. The child was born to
a 23 year-old mother at 33 weeks 5 days by vaginal deliv-
ery in a local private hospital. He was 1400 gm at birth
and was in nursery for first 20 days after birth. He was first
born child of the couple. His record of length and head
circumference was not available. There was no history of
antenatal complications. Suckling was defective through-
out infancy for which he was spoon fed until one year of
age and never breast fed. He had recurrent episodes of
upper respiratory infection including fever since infancy
for which he was admitted several times in private hospi-
tal for the treatment. His milestone was delayed; unable to
speak, walk or stand up even at age of 2 years ten months.
He has no dyspnoea or cyanosis. There was no similar
problem in the family excepting squint in mother and
beta thalassaemia major in paternal side.
Physical examination revealed dysmorphic features &
generalized hypotonia. He had short & broad nose, small
mouth, down turn upper lip, hypertelorism, telecanthus
and squint (Fig. 1A). Ears were low set, deficient in vertical
diameter and dysplastic. Palate was high arched. Hands &
fingers were long and slender. His weight was 9 kg and
height was 75.5 cm (both below 3rd percentile). Head cir-
cumference was 45 cm (below -2SD/below 2nd percen-
tile), however proportionate to height & weight. His
developmental quotient was between 41–45% of
expected. Ophthalmologic examination was revealed
squint. Extensive cardiovascular work up including
echocardiography revealed mild pulmonary stenosis,
large malaligned ventricular septal defect, dilated aortic
root and was suggestive of tetralogy of Fallot. CT scan of
head & brain was normal. There was no hypocalcemia.
Conventional cytogenetics from lymphocyte culture was
normal.
Since the patient had findings strongly suggestive of
22q11.2 microdeletion syndrome FISH study to detect a
possible deletion in the critical 22q11.2 region was done
using PAC/BAC clones specific for 22q11.2 locus (RP5-
882J5 & CTA-154H4 obtained from Uniba Biologia, Italy,
by curtsy of Prof. M Rocchi). Interphase FISH was done
using 1 ml of blood obtained from the patient. Blood
nucleated cells washed in phosphate buffer saline solu-
tion three times before 30 minutes hypotonic treatment
(50 mMol KCL) and fixation in methanol:acetic acid solu-
tion (3:1 ratio). Cells re-suspended in 100 ul fresh fixative.
Approximately 20 ul cell suspension was used to prepare
a slide. PAC/BAC clones were grown in LB broth, DNA
extracted and about 1 ug DNA was labeled with green
flurochrome (FITC) or red flurochrome (Cy3) by nick
translation method. About 100 ng labeled probe was used
for FISH. FISH analysis was carried out using Olympus
BX51 microscope with epifluorescence attachment and
image was captured through spectral imaging system. A
total of 1312 interphase nuclei were scored. Interphase
FISH result showed 1100 (83.8%) nuclei with
hemizygous deletion for 22q11.2 locus and 210 (16%)
nuclei with normal diploid state (Fig. 1B). Normal control
cases displayed two signals in approximately 98% nuclei
whereas positive controls displayed hemizygous deletion
in approximately 98% nuclei. This finding was conclusive
for mosaic 22q11.2 microdeletion with presence of low
level of normal cells. FISH on metaphase spread pick up
deletion in all excepting one of 25 metaphases studied.
Interphase FISH was also carried out on buccal cells and
urinary cells as described before [11] to find out whether
mosaicism restricted to blood or generalized. Mosaicism
was confirmed in all three types of cells (Table 1). Parents
were also screened for deletion and results were negative.
A is showing broad nose, square shaped tip of nose, small  philtrum, hypertelorism, telecanthus, squint and low set ears Figure 1
A is showing broad nose, square shaped tip of nose, 
small philtrum, hypertelorism, telecanthus, squint 
and low set ears. B is showing 22q11.2 FISH with deletion 
(most cells) and without deletion (arrow) on interphase cells 
obtained from peripheral blood.Molecular Cytogenetics 2008, 1:18 http://www.molecularcytogenetics.org/content/1/1/18
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Case 2
A one and half year old male child was referred from a vil-
lage near Sirsa, Haryana, India to our hospital for cardiac
malformation and facial dysmorphism. Pediatric geneti-
cist referred the child to us to evaluate for 22q11.2 micro-
deletion syndrome. The child was born to a 27 year-old
mother at term by vaginal delivery at local hospital. He
was 1750 gm at birth. He was second born child of the
non-consanguineous couple and his elder 3 years old sis-
ter was normal. His record of length and head circumfer-
ence at birth was not available. There was no history of
antenatal complications. However, early neonatal period
was complicated by unconjugated hyperbillirubinemia
that was managed by phototherapy. Suckling was normal
however prone to have recurrent episode of vomiting in
later part of infancy following intake of foods other than
milk. His milestone was grossly delayed. He has signifi-
cant dyspnoea since last six to seven months. There was
no similar problem in the family in either side.
Physical examination revealed dysmorphic features &
generalized hypotonia. Most prominent feature was trigo-
nocephaly with metopic prominence leading to forehead
prominence. His head circumference was 45 cm (below -
2 SD/below 2nd percentile). He had short & broad nose,
small mouth, wide philtrum, thin upper lip, hyperte-
lorism, telecanthus and upward slanting almond shaped
eyes (Fig. 2A). Ears were low set. Ophthalmologic & audi-
tory examination revealed no abnormality. He had central
cyanosis and significant clubbing of fingers. Extensive car-
diovascular work up including echocardiography was sug-
gestive of tetralogy of Fallot with reversal of flow. An X ray
skull and CT scan (Fig. 2B) of head & brain was consistent
with craniosynostosis (due to premature metopic suture
fusion). There was no hypocalcemia. Conventional
cytogenetics from lymphocyte culture was normal.
Since the patient had findings suggestive of 22q11.2
microdeletion syndrome FISH study was done using PAC/
BAC clones specific for 22q11.2 locus (RP5-882J5 & CTA-
154H4, obtained from Uniba Biologia, Italy, by curtsy of
Prof. M Rocchi). A total of 1046 interphase nuclei were
scored. Interphase FISH result showed 121 (11.6%)
nuclei with hemizygous deletion for 22q11.2 locus and
925 (88.4%) nuclei with normal diploid state. About 15%
metaphase also showed hemizygous deletion (Fig. 2C).
Interphase FISH was also carried out on buccal cells and
urinary cells to find out whether mosaicism restricted to
blood or generalized. Mosaicism was confirmed in all
three types of cells (Table 1). Parents were also screened
for deletion and results were negative.
Discussion and conclusion
In this report we have presented two cases of mosaic
22q11.2 microdeletion syndrome. Both of our cases had
tetralogy of Fallot along with facial dysmorphism despite
low level of deleted cells (~15%) in case 2. Mosaicism in
22q11.2 microdeletion syndrome is rare and only a few
cases [Table 2] have been described in literature [7-9,12]
with variable manifestation viz. early death [8,9] to
asymptomatic carrier parents [7,9]. Mosaic full mono-
somy of chromosome 22 that may present similar to
22q11.2 microdeletion syndrome is also rare [Table 2]
and reported few occasions [13-17] with variable manifes-
tation. Similarly, reports of mosaic 22q11.2 deletion with
duplication also have been described in the literature on
Table 1: Details of FISH results of cases and their parents
Parameters One Signal
 (%)
Two Signals
 (%)
Other Signals
 (%)
Total
 Cells
Remarks
Patient 1
Blood Interphase 1100
(83.8)
0210 (16) 0002 (0.2) 1312 16% normal cells
Blood Metaphase 0024 0001 0000 0025 One normal cell (4%)
Buccal Cells 0014
(77.8)
0004 (22.2) 0000 0018 22.2% normal cells
Urinary Cells 0008
(88.9)
0001 (11.1) 0000 0009 11.1% normal cells
Mother's Blood (interphase) 0000 0100 0000 100 Normal
Father's Blood (interphase) 0001 0081 0001 0083 Normal
Patient 2
Blood Interphase 121 (11.6) 925 (88.4) 000 1046 88.4% normal cells
Blood Metaphase 006 (15) 034 (85) 000 040 85% normal cells
Buccal Cells 008 (13.8) 050 (86.2) 000 058 86.2% normal cells
Urinary Cells 007 (14.6) 041 (85.4) 000 048 85.4% normal cells
Mother's Blood (metaphase) 000 030 000 030 Normal
Father's Blood (metaphase) 000 020 000 020 NormalMolecular Cytogenetics 2008, 1:18 http://www.molecularcytogenetics.org/content/1/1/18
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2 occasions [Table 2; [18,19]]. Chen et al. (2004) [7]
described a fetus with mosaicism for 22q11.2 hemizygous
microdeletion (a ratio of 43 deleted: 57 normal) on amni-
ocytes using FISH technique. The case had cardiac malfor-
mation typical of tetralogy of Fallot along with thymic
hypoplasia. The father of fetus also had mosaic 22q11.2
microdeletion (a ratio of 19 deleted: 81 normal) however
completely asymptomatic. Patel et al. (2006) [9] reported
another case of mosaicism for 22q11.2 microdeletion in
fetal cardiac tissue as well in maternal lymphocytes (10%)
by FISH analysis. Similarly, Consevage et al 1996 [8] and
Hatchwell et al 1998 [12] reported mosaic 22q11.2 micro-
deletion in lymphocytes and germ cells, respectively.
Dempsey et al (2007) [18] and Blennow et al (2008) [19]
reported two more cases of mosaicism. However, patients
were mosaic for two abnormal cell lines instead of nor-
mal/abnormal cell lines: a deletion
[del(22)(q11.2q11.2)] and duplication
[dup(22)(q11.2q11.2)].
Due to variable manifestation from case to case or familial
transmission with this syndrome many authors were
looked for mosaicism, including tissue specific. However,
outcome were contradictory; some had proven (cardiac
tissue) [9] or disproven [5,20,21] while others suspected
for gonadal mosaicism [22,23] with different laboratory
approaches. Ideal laboratory approach to diagnose mosa-
icism should be interphase FISH as other method, includ-
ing QF PCR/MLPA can not detect low level mosaicism due
to the presence of a normal cell line, which would mask
the appearance of deleted 22q11.2 region. Since inter-
phase FISH analysis can assess large numbers of individ-
A is showing broad & short nose, small moth, wide philtrum, thin upper lip, hypertelorism, telecanthus, upward slanting almond  shaped eyes, low set ears and forehead prominence Figure 2
A is showing broad & short nose, small moth, wide philtrum, thin upper lip, hypertelorism, telecanthus, 
upward slanting almond shaped eyes, low set ears and forehead prominence. B is CT scan of skull showing fusion of 
metopic suture. C is showing 22q11.2 FISH on lymphocytes (metaphase & interphase cells) without and with deletions (arrow).Molecular Cytogenetics 2008, 1:18 http://www.molecularcytogenetics.org/content/1/1/18
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ual cells very quickly this technique can pick up even low
level of mosaicism. Our second case emphasizes the
importance of interphase FISH in the diagnosis of low
level of mosaicism despite strong clinical manifestations.
To establish a mosaicism, as we followed & confirmed (on
metaphase as well as with another probe), a repeat blood
sample should always be analyzed along with other tis-
sues viz. buccal cells (ectodermal origin) &/or urine cells
(endodermal origin). However, one should take precau-
tion before diagnosing a mosaicism that hemizygous sig-
nal drop is frequent with interphase FISH (also influenced
by type of tissue and probes) [24,25]. In our hand
22q11.2 locus specific probe (RP5-882J5 & CTA-154H4)
provides hemizygous results in 1.76% interphase lym-
phocyte nuclei of normal individuals and we had taken
care before diagnosing low level mosaicism (i.e., also con-
firmed by metaphase FISH & second adjacent probe at
22q11.21 locus i.e., CTA-154H4 BAC clone; metaphase
FISH does not give rise to hemizygous deletion in normal
controls).
We also report on the association of trigonocephaly, one
type of craniosynostosis, in one child with the mosaic
22q11.2 microdeletion. Yamamoto et al. (2006) [10]
reported first time one patient with 22q11.2 microdele-
tion and craniosynostosis of the metopic suture leading to
trigonocephaly. They suggested craniosynostosis of the
metopic suture might be a minor complication, although
coincidental occurrence cannot be ruled out. Here, we
have encountered with another patient of 22q11.2 micro-
deletion (mosaic) with trigonocephaly derived from
craniosynostosis of the metopic suture. This is the second
report of a relationship between microdeletion 22q11.2
and trigonocephaly. Although trigonocephaly is rare with
22q11.2 microdeletion, it is commonly seen with mono-
somy 9p [26]. However, other form of craniosynostosis
Table 2: Published reports on mosaic 22q11.2 microdeletion and mosaic monosomy 22
SN References Case description in brief Method used Results
Mosaic 22q11.2 deletion
1 Chen et al 2004 [7] Fetus with tetralogy of Fallot & 
thymic hypoplasia
Father asymptomatic
Interphase FISH on amniocytes
Interphase cells from cord blood
Interphase FISH on lymphocytes
61% deleted interphase cells
43% deleted interphase cells
19% deleted interphase cells
2 Consevage et al 1996 [8] Female newborn with facial 
dysmorphism, hypoplastic left 
heart syndrome & growth 
retardation
Metaphase FISH in lymphocytes 16% metaphases with deletion
3 Patel et al 2006 [9] Missed abortion at 16 weeks 
gestation
Asymptomatic carrier mother
Interphase FISH on heart tissue 
Lymphocytes
Cells with & without deletions
10% deleted cells
4 Hatchwell et al 1998 [12] Mother with 2 affected & one 
unaffected child
FISH & haplotype analysis Germ line mosai-cism in mother
Mosaic monosomy 22
5 Pinto-Escalante et al 1998 [13] Dysmorphism, joint contracture, 
scleroderma, hypertrichosis, 
hypertonicity, etc
Karyotype from lymphocyte 
culture
15% monosomic cells
6 Verloes A et al 1987 [14] A child with mild facial 
dysmorphism and mentally 
deficiency
Karyotype on lymphocytes & 
fibroblast cells
10.5% & 8.3% monosomic cells, 
respectively
7 Sabui and Chakrobarty 1997 [15] Female child with facial 
dysmorphism & failure to thrive 
including developmental delay
Karyotype on lymphocytes 70% monosomic cells
8 Lewinsky et al 1990 [16] Fetal gastroschisis with absent 
cerebral diastolic flow
Karyotype Mosaic monosomy 22
9 Moghe et al 1981 [17] Male child with facial dysmor-
phism, psychomotor retardation, 
hypotonia & syndactyly
Karyotype on lymphocytes 25% monosomic cells
Mosaic 22q11.2 deletion & 
duplication
10 Dempsey et al 2007 [18] Twin newborn, one normal & 
other with cardiac malformation 
as well as hypocalcemia, later 
delayed development and 
recurrent infections
FISH on metaphase of 
lymphocytes
FISH on metaphase of skin 
fibroblasts
FISH on interphase skin fibroblast 
cells
Deletion in 55% cells; duplication 
in 45% cells
Deletion in 86% cells; duplication 
in 14% cells
80% deleted cells
11 Blennow et al. 2008 [19] Girl with dysmorphism but no 
cardiac malformation
Lymphocytes Deletion in 70% cells; duplication 
in 100% cellsMolecular Cytogenetics 2008, 1:18 http://www.molecularcytogenetics.org/content/1/1/18
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with 22q11.2 microdeletion syndrome is not so rare and
reported in some previous occasions [27-31]. Ryan et al.
(1997) [31] described five patients of microdeletion
22q11.2 syndrome with craniosynostosis without
description of its type. McDonald-McGinn et al. (2005)
[30] reported on the presence of craniosynostosis in
another four patients with the 22q11.2 microdeletion
syndrome. Similarly, De Silva et al. (1995), Karteszi et al.
(2005), Dean et al. (1998), etc [27-29] reported some
more cases of craniosynostosis in patient with microdele-
tion 22q11. In light of previous repeated reports of the
association, we assume that craniosynostosis including
trigonocephaly may be a rare manifestation of the
22q11.2 microdeletion syndrome. However, it seems that
12–15% mosaicism for 22q11.2 microdeletion may not
solely account for the condition and the possibility of
another undetected condition can not be ruled out. Crani-
osynostosis is also commonly seen with other chromo-
some deletions viz., with chromosome 15q
(del(15)(q15q22.1) [32]; with chromosome 7p- [33-36]
and 2q- [37]. Familial transmission of a 22q11.2 microde-
letion accounts for 8 to 25% of the cases [38,39] and par-
ents with deletions may be asymptomatic or mildly
affected. However, none of the parents in our cases were
carrier for the microdeletions.
We conclude that mosaic 22q11.2 microdeletion is not
very rare if investigated with interphase FISH, can present
as severe phenotype even in the presence of low level of
deleted cells and trigonocephaly/craniosynostosis may be
a rare manifestation.
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